Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease.
Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, Fracanzani AL, Rosso C, Blanco MJG, Armandi A, Caviglia GP, Zaki MYW, Liguori A, Francione P, Pennisi G, Grieco A, Valenti L, Anstee QM, Bugianesi E.
Younes R, et al. Among authors: liguori a.
Am J Gastroenterol. 2020 Aug;115(8):1289-1292. doi: 10.14309/ajg.0000000000000676.
Am J Gastroenterol. 2020.
PMID: 32453041
Free article.